6th February 2017

SilverCloud Health Raises $8.1 Million

Digital Health company SilverCloud Health, the leading provider of evidence-based online mental health and behavioural healthcare solutions, announced that it has raised $8.1 million in Series A funding. Venture capital firm B Capital Group – founded by Raj Ganguly and Facebook co-founder Eduardo Saverin – led the investment round with significant participation from ACT Venture Capital and returning investors, Investec Ventures and AIB Seed Capital Fund managed by DBIC, NDRC and Enterprise Ireland.

SilverCloud Health is a multi-award winning global health tech company; since launching in 2012 it has gone on to support over 80,000 patients across its global customer base, delivering clinical results that are on par with face-to-face therapy.

SilverCloud Health chief executive and co-founder Ken Cahill said the company is defining a new healthcare model to meet the demand of the rapidly growing behavioral healthcare market, which in the US alone is estimated to be worth $440 billion. “This new investment enables us to drive forward with our commitment to evolve our health platform and address the ever-increasing global need in behavioral healthcare. We believe that technology is the enabler to address the biggest healthcare challenge of this century, maximizing clinical delivery while enhancing patient access and choice, through the ability to engage with therapy at a time that fits into diverse lifestyles and through devices that are a part of our everyday lives.”

“We chose B Capital to lead our Series A because of their healthcare knowledge and relationships, and due to their partnership with The Boston Consulting Group, which has opened doors for us to new commercial partners in the US,” he added.

“SilverCloud Health’s mission is to make people healthier by providing effective, accessible and affordable behavioral healthcare opportunities, filling a massive void in the market today. B Capital Group is excited to back Ken and the team at SilverCloud Health, as they continue to change the way behavioral healthcare is delivered,” said Eduardo Saverin, Co-founder and Partner, B Capital Group. “Our investment in SilverCloud Health is driven by our confidence in its team, its proven track record working with global health organizations and its esteemed partner network. This new capital will enable SilverCloud Health to continue to innovate, expand and broadly deploy its programs to the millions of individuals who need them.”

This funding round comes as SilverCloud Health is growing rapidly with an expanding research pipeline that continues to show the clinical effectiveness of the company’s behavioral health platform. The SilverCloud Health platform is currently used by over 120 healthcare organizations across North America and Europe. Within the UK National Health Service (NHS), the company has seen an exponential growth of clients-from supporting 1 percent of NHS mental health services two years ago to over 45 percent today. The new capital will be used to meet growing demand in North America and Europe, build out its commercial, development and clinical teams and drive its strong clinical research and publishing agenda.

With proven results in major health systems globally this investment will allow expansion into new areas such as integration with personal health and activity monitoring devices to give a more integrated personalized context across physical and behavioral healthcare.

Gavin Teo, Partner at B Capital Group said, “SilverCloud Health is redefining access to quality, outcomes-based care for hard-to-treat and high cost behavioral health populations. Their digital health platform is enabling new ways for provider systems and pharma companies to personalize therapeutic delivery to the individual patient, which is a building block for clinically validated, value driven care. B Capital is thrilled to be the lead investor in SilverCloud Health at such an exciting time in their growth.”

“We’ve seen SilverCloud’s impact on patients and clinicians. Patients have seen it transform their daily lives, with a therapy they can control, and clinicians have been able to rapidly integrate it into clinical pathways,” says John O’Sullivan, General Partner at ACT Venture Capital. “The efficacy data is compelling and is evident across a very large and diverse range of cases. We are delighted to be working with the SilverCloud team to positively impact and change many more lives and transform the economics of healthcare delivery.”